price
-
Financial
Xtant Medical Announces Adjustment to Subscription Price of Rights Offering
BELGRADE, Mont., Nov. 09, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Globus Medical Inc (NYSE:GMED) Receives $27.67 Average Target Price from Analysts
by Trevor Kearing – May 29, 2016 Globus Medical Inc (NYSE:GMED) has been given a consensus rating of “Hold” by…
Read More » -
Financial
Increased demand for specialized OR tables drives up average price
By Adam Rubenfire The average cost of operating room tables increased this year as more providers purchased orthopedic specialty and…
Read More » -
Financial
Millions choose IRS fines as more affordable than health coverage
By Abby Goodnough Clint Murphy let the deadline for getting health insurance by the new year pass without a second…
Read More » -
Financial
Company Shares of Orthofix International N.V. (NASDAQ:OFIX) Drops by -2.8%
Orthofix International N.V. (NASDAQ:OFIX) has lost 2.8% during the past week and dropped 1.68% in the last 4 weeks. The…
Read More » -
Financial
Earnings in Focus: Amsurg Corp. (NASDAQ:AMSG)
Amsurg Corp. (NASDAQ:AMSG) is expected to announce their quarterly earnings on 2016-02-24 according to the latest information available. Investors will…
Read More » -
Financial
Integra Lifesciences Holdings Corp (IART) Earns “Buy” Rating from Oppenheimer
By Maddie Sorenson Integra Lifesciences Holdings Corp (NASDAQ:IART)‘s stock had its “buy” rating reaffirmed by investment analysts at Oppenheimer in…
Read More » -
Financial
Update: Amsurg Corp. Short Interest Disclosure
Amsurg Corp. (NASDAQ:AMSG) stated gains of 95,280 shares or 3.3% in the short interest. The short interest registered from 2,898,016…
Read More » -
Financial
Amsurg Corp. Price Target Update
Amsurg Corp. (NASDAQ:AMSG): The stock price is expected to reach $ 91.7 in the short term. The number of analysts…
Read More » -
Financial
J. Goldman & Company Sells Position in CONMED Co. (CNMD)
By Thomas Dobrow J. Goldman & Company closed out its position in shares of CONMED Co. (NASDAQ:CNMD) during the third…
Read More » -
Financial
Zacks Investment Research Lowers Osiris Therapeutics, Inc. (OSIR) to Sell
By Jeff Rose Zacks Investment Research lowered shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) from a hold rating to a sell…
Read More » -
Financial
Osiris Therapeutics, Inc. (OSIR) Downgraded by Zacks Investment Research to Sell
By Mark Watkins Osiris Therapeutics, Inc. (NASDAQ:OSIR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a…
Read More » -
Financial
CONMED Co. (CNMD) Sees Strong Trading Volume on Insider Buying Activity
By Maddie Sorenson CONMED Co. (NASDAQ:CNMD) saw unusually-strong trading volume on Tuesday after an insider bought additional shares in the…
Read More » -
Financial
CONMED Corporation (NASDAQ:CNMD)’s Company Shares Increased 4.48% After Low Volatility
By Justin Falconi The shares of CONMED Corporation (NASDAQ:CNMD) increased by 4.48% in the last 20 days but lost 3.66%…
Read More » -
Biologics
Amedica Corporation Amends Series A and C Warrants
SALT LAKE CITY, Dec. 14, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics…
Read More »